Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.04 +0.13 (+3.32%)
At close: Sep 30, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Current Deferred Revenue (2024 - 2026)

Updated

Camp4 Therapeutics' Current Deferred Revenue was $13.01 million in Q2 2026, up 17.5% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, Current Deferred Revenue at Camp4 Therapeutics came in at $9.39 million.

  • In earlier years, Current Deferred Revenue was $385,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Camp4 Therapeutics 203.03 Mn 203.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.01 Mn
Mar 31, 2026 11.08 Mn
Dec 31, 2025 9.39 Mn
Dec 31, 2024 385,000.00
Sep 30, 2024 1.00 Mn
API Access

Camp4 Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CAMP&period=max&api_key=YOUR_API_KEY